Site-directed mutagenesis for DnaA
DnaA 定点诱变
基本信息
- 批准号:09672236
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Re-replication of DNA from a newly replicated origin is normally suppressed so that coupling of DNA replication with cell division proceeds in an orderly manner. However, the molecular mechanisms for suppression remains unknown, even in prokaryotic cells. In my previous research, I demonstrated that the intrinsic ATPase activity of DnaA protein, the initiation factor for ANA replication in Escherichia coli cells, play a major role in the suppression ofre-replication by inactivating the DnaA function. I also found a stimulation factor for the DnaA ATPase activity and showed that the factor was activated only after the initiation of DNA replication. Based on these results, I proposed a new model for the suppression of re-initiation in Escherichia coli cells. In details, we constructed mutant DnaA protein whose ATPase activity is specifically decreased and showed that induction of a mutated DnaA protein caused over-initiation of chromosomal DNA replication in cells, resulting in a dominant lethal phenotype. These observations suggest that the intrinsic ATPase activity of DnaA protein is involved in the suppression of re-initiation from newly replicated origin in cells
来自新复制起点的DNA的再复制通常被抑制,使得DNA复制与细胞分裂的偶联以有序的方式进行。然而,即使在原核细胞中,抑制的分子机制仍然未知。在我以前的研究中,我证明了DnaA蛋白(ANA在大肠杆菌细胞中复制的起始因子)的内在ATP酶活性通过使DnaA功能失活而在抑制再复制中起主要作用。我还发现了DnaA ATP酶活性的刺激因子,并表明该因子仅在DNA复制开始后才被激活。基于这些结果,我提出了一个新的模型,抑制大肠杆菌细胞中的重新启动。详细地说,我们构建了ATP酶活性特异性降低的突变DnaA蛋白,并表明突变DnaA蛋白的诱导引起细胞中染色体DNA复制的过度起始,导致显性致死表型。这些观察结果表明,DnaA蛋白的内在ATP酶活性参与抑制细胞从新复制的起点重新启动
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nozaki, K., et.al: "A new Na_+/H_+ antiporter, NhaD,of Vibrio parahaemolyticus." Biochim.Biophys.Acta.1369. 213-220 (1998)
Nozaki, K. 等人:“副溶血弧菌的一种新的 Na_ /H_ 逆向转运蛋白 NhaD。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ohba, A., et.al: "Amounts of proteins alterd by mutations in the pgsA gene of Escherichia coli" (IN PRESS).
Ohba, A. 等人:“大肠杆菌 pgsA 基因突变改变的蛋白质数量”(新闻中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hase,M: "Site-directed mutational analysis for the membrane-binding of DnaA protein" J.Biol.Chem.273. 28651-28656 (1998)
Hase,M:“DnaA 蛋白膜结合的定点突变分析”J.Biol.Chem.273。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ogawa,W: "Cloning and expression of the gene for the Na+-coupled serine transporter from Escherichia coli and characteristics of the transporter." J.Bacteriol.in press.
Okawa,W:“大肠杆菌 Na 偶联丝氨酸转运蛋白基因的克隆和表达以及转运蛋白的特征。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mizushima,T.: "Supression of Ethanol-induced Apototic DNA Fragmentation by Geranylgeranylacetone in Cultured Guinea Pig Gastric Mucosal Cells." Digest.Dis.Sci. (in press).
Mizushima,T.:“在培养的豚鼠胃粘膜细胞中香叶基香叶基丙酮抑制乙醇诱导的细胞凋亡 DNA 断裂。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIZUSHIMA Tohru其他文献
MIZUSHIMA Tohru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIZUSHIMA Tohru', 18)}}的其他基金
Mechanism for anti-AD effect of approved medicines
已批准药物的抗 AD 作用机制
- 批准号:
24659037 - 财政年份:2012
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Induction of stress proteins by NSAIDs and its role in their pharmacological activity
NSAIDs 诱导应激蛋白及其在药理活性中的作用
- 批准号:
19390023 - 财政年份:2007
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of the activity of ORC.
ORC 活动的监管。
- 批准号:
17390021 - 财政年份:2005
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Re-constitution of pre-RC complex
预 RC 复合体的重建
- 批准号:
12470499 - 财政年份:2000
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
- 批准号:81673007
- 批准年份:2016
- 资助金额:54.0 万元
- 项目类别:面上项目
相似海外基金
Functional analysis of miRNA in anti-cancer drug-resistance of hepatocellular carcinoma
miRNA在肝细胞癌抗癌耐药中的功能分析
- 批准号:
22K07473 - 财政年份:2022
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dissecting the relevance of RNA regulatory mechanisms in anti-cancer drug-induced heart failure
剖析 RNA 调节机制在抗癌药物引起的心力衰竭中的相关性
- 批准号:
21K20889 - 财政年份:2021
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
A new platform of acidic pH-responsive polymeric micelles for anti-cancer drug delivery
用于抗癌药物输送的酸性 pH 响应聚合物胶束的新平台
- 批准号:
534064-2019 - 财政年份:2021
- 资助金额:
$ 1.92万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Design of three-dimensional tissue models for anti-cancer drug screening utilizing growth factor release system
利用生长因子释放系统设计抗癌药物三维组织模型
- 批准号:
21K20517 - 财政年份:2021
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
CCN2-oriented anti-cancer drug screening
面向CCN2的抗癌药物筛选
- 批准号:
21K17104 - 财政年份:2021
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Multimodal cancer therapy by combination of immune therapy and targeting nanostructured carrier containing anti-cancer drug
免疫治疗与含有抗癌药物的靶向纳米结构载体相结合的多模式癌症治疗
- 批准号:
21H04965 - 财政年份:2021
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of new anti-cancer drug with anti-apoptotic protein MCL-1 selective inhibitory activity
具有抗凋亡蛋白MCL-1选择性抑制活性的新型抗癌药物的开发
- 批准号:
20K06977 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A new platform of acidic pH-responsive polymeric micelles for anti-cancer drug delivery
用于抗癌药物输送的酸性 pH 响应聚合物胶束的新平台
- 批准号:
534064-2019 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Development of molecules which suppress cytotoxicity by anti-cancer drug through novel Ghrelin receptor signaling
通过新型 Ghrelin 受体信号传导抑制抗癌药物细胞毒性的分子的开发
- 批准号:
20K07293 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of anti-cancer drug targeting cancer stem cells
开发针对癌症干细胞的抗癌药物
- 批准号:
20H03407 - 财政年份:2020
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




